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Abstract
The aim of this study was to assess experienced depression and anxiety among early breast cancer patients during radiotherapy.
Women who started radiotherapy for breast cancer (n = 125) were asked to answer two questionnaires: The Hospital Anxiety and
Depression Scale (HADS) and Radiotherapy Categorical Anxiety Scale during radiation therapy. The highest mean for anxiety
and depression was for those who received education more than BA (SD = 3.2) and those who received less than secondary
education (SD = 3.16), respectively. Also, the highest mean for patients’ number of children related with anxiety was for those
who have more than three children (SD = 2.87), while for depression was (SD = 3.01). Anxiety and depression were also
correlated to patient age where both showed the highest mean for those who aged between 31 and 40 (SD = 2.89), and those
who are more than 51 years old (SD = 3.15), respectively. The highest anxiety and depression mean for treatment duration was
for those treated for more than 3 months (SD = 3.2), and for those treated between 1 and 3 months (SD = 3), respectively. Some
intervention may be needed to decrease the temporary anxiety and depression raised during radiotherapy for early-stage breast
cancer patients.
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Introduction
The objective of cancer treatment is to cure cancer and pro-
long life, and when not possible, it is used in palliation [1].
Breast cancer among females is one of the most common
cancer types worldwide, in which 1 out of 8 women could
be diagnosed with the breast cancer during their lifetime [2].
Cancer treatment can be carried out by one of the three main
modalities. These include surgery, radiotherapy, and chemo-
therapy. The chemotherapy is an intense treatment which has
many side effects. The side effects of chemotherapy are well
documented and include nausea and vomiting, alopecia, pe-
ripheral neuropathy, and myelosuppression [3–5]. Even
though chemotherapy may prolong survival rates for ad-
vanced cancer cases in a modest way [6], cytotoxic chemo-
therapy was unable to cure many metastasized cancers. The
well-being of survivors is accompanied by problems which
include physical symptoms and psychological reactions that
can bring life disruption [7]. A 5-year-survival study on the
contribution of cytotoxic chemotherapy shows that the contri-
bution of curative and adjuvant chemotherapy in adults was
around 2.3% in Australia and 2.1% in the USA [8]. Many
factors can affect the mentality and psychological condition
of patients undergoing radiation therapy. These include long
treatment periods, hospitalizations, and the knowledge of hav-
ing cancer. In the context of cancer, distress is defined as
extending along a continuum ranging from common normal
feelings of vulnerability, sadness, and fear to problems that
can become disabling such as depression, anxiety and panic,
social isolation, and spiritual crisis [9]. However, anxiety is
the most commonly seen in cancer patients. It can occur in
four forms: (1) situational anxiety, (2) disease-related anxiety,
(3) treatment-related anxiety, and (4) exacerbation of pre-
treatment anxiety disorder [10]. Despite the effect distress
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has on daily functioning, depression and anxiety in cancer
patients are often underestimated [11]. Usually, breast cancer
patients experience anxiety, depression, and fatigue months to
years after being diagnosed with breast cancer [12]. The aim
of this study was to assess experienced depression and anxiety
among early breast cancer patients undergoing radiotherapy.
Methods
Approach
The study adopted the quantitative research method. The
questionnaire is suitable for the exploratory nature of the
research.
Population and Sample
The population of the study included all cancer patients at-
tending Augusta Victoria Hospital radiotherapy division. The
sample consisted of 125 female breast cancer patients, who
provided their consent by completing the survey, as explained
in the survey cover. This study was approved by the ethics
committee of the Augusta Victoria Hospital in Jerusalem,
Palestine. The demographic characteristics of the participants
were as follows: level of qualification, number of children,
age, and the duration of treatment. Respondents were between
20 and 60 years of age. Half (52.53%) of the participants were
satisfied with their salary, and nearly 45.4% having more than
three children. The inclusion criteria are (1) woman, 18 years
of age and above, (2) diagnosed with breast cancer, (3) no
history of mental disorder or dementia, (4) adequate knowl-
edge of Arabic/English languages and satisfactory level of
communication, and (5) consent to participate in the study.
Any patient previously diagnosed with psychiatric condition
was excluded from the study.
All patients were asked to answer two questionnaires: The
Hospital Anxiety and Depression Scale (HADS) and
Radiotherapy Categorical Anxiety Scale during radiotherapy.
The prevalence of anxiety and depressive disorders were re-
ported in percentage. The association between psychosocial,
demographics, and anxiety and depression were analyzed by
ANOVA test. A p value of less than 0.05 was considered
statistically significant.
The reliability of the study tool was verified using Pearson
correlation coefficient for questionnaire questions and parts.
Additionally, the stability of the study tool was determined
using Cronbach alpha. Results indicate that the study tool
was suitable to apply on study population (Cronbach alpha =
0.81). The total number of collected and analyzed question-
naires was 125.
Statistical Analysis
Data statistical analysis was carried out using SPSS version
26.0 (IBM, Chicago, Illinois, USA). Means and standard de-
viations for every part of the questionnaire using one-way
ANOVA and Pearson correlation coefficient were reported.
Results
The sample consisted of 125 breast cancer patients treated by
radiation therapy at Augusta Victoria Hospital at Jerusalem.
Table 1 shows study population and their demographic infor-
mation, including educational qualification, number of chil-
dren, age, and duration of treatment. According to educational
qualifications, there were 36.8% patients who received less
than secondary school education, while 59.2% of them re-
ceived BA degree, and about 4% received further higher edu-
cation beyond BA.
Results reveal that most of the sample (59.2%) were sec-
ondary school qualified. The majority of them (34.4%) are
within the age groups 51 and above; 42% received radiation
treatment for about 3 months. As for the number of children
each patient has, it was noted that 14.4% of patients have no
children, 3.2% have one child, 17.6% have two children, and
64.8% have more than three children. Regarding patient age,
11.2% fell in the age range between 23 and 30 years old,
28.8% in the 31–40 age range, 25.6% in the 41–50 age range,
and 34.4% were older than 51 years old. As for the radiation
Table 1 Demographic characteristics of participants (n = 125)
Characteristic Frequency Percentages (%)
Qualification
Less than secondary school 46 36.8
Secondary school—MA 74 59.2










More than 51 43 34.4
Duration of treatment
Less than a month 30 24.0
One to 3 months 53 42.4
More than 3 months 42 33.6
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treatment duration, 24% of patients had less than a month
duration, while 42.2% of patients received radiation treatment
for a period between 1 and 3 months.
Table 2 shows that the highest mean for anxiety correlated
with educational qualification was for those who received
education more than BA (SD = 3.2), while for depression
was for those who received less than secondary education
(SD = 3.16). Additionally, the highest mean for patients’ num-
ber of children related with anxiety was for those who have
more than three children (SD = 2.87), while for depression
was (SD = 3.01). As for patient age correlation with anxiety,
the highest mean was for those who aged between 31 and 40
(SD = 2.89), and for depression, the highest mean was for
those who are more than 51 years old (SD = 3.15). The treat-
ment duration shows that the highest anxiety mean was for
those treated for more than 3 months (SD = 3.2), while the
highest depression mean was for those treated between 1
and 3 months (SD = 3).
The result reveals that there were no significant differences
found in the level of depression for all variables, whereas there
was a significant difference in the level of anxiety with the
duration of treatment, especially for treatments over 3 months.
The total depression point (SD = 2.94) was higher than the
anxiety (SD = 2.78) for breast cancer patients undergoing ra-
diation therapy. There were differences between patients’ re-
sponses with treatment duration variable, and it was signifi-
cant for those treated for more than 3 months (p value < 0.04).
Table 3 shows a positive correlation between anxiety and
depression, meaning that, whenever anxiety increases, depres-
sion increases and vice versa.
Discussion
The current study assessed the level of psychological distress of
breast cancer patients undergoing radiotherapy in Palestine.
Our study showed substantial levels of depression and anxiety
among cancer patients undergoing radiotherapy. Results show
that depression was generally higher than anxiety among
Palestinian breast cancer patients treated with radiation therapy,
which could be due to the beliefs that cancer is fatal and because
about 50% of the respondents diagnosed with breast cancer
were in younger age group (below 40s), which could be linked
to high levels of depression [13, 14]. In addition to the difficulty
in reaching the only available radiation therapy facility located
in Jerusalem for Palestinian people (Augusta Victoria Hospital),
it needs a patient from theWest Bank to obtain an Israeli permit
to enter and reach any facility within Jerusalem, which is not
easy to apply for and not always guaranteed to get.
Table 2 Comparison of
depression and anxiety scores in
treated patients using mean scale
and subscale scores of one-way
ANOVA





Less than secondary education 2.81 ± 0.94 0.49 3.16 ± 0.85 0.06
Secondary education—MA 2.73 ± 0.78 2.81 ± 0.77
Higher than MA 3.20 ± 1.23 2.68 ± 1.01
Number of children
None 2.84 ± 0.47 0.20 2.83 ± 0.60 0.22
One 2.53 ± 0.35 2.17 ± 0.96
Two 2.45 ± 0.61 2.90 ± 0.85
Three or more 2.87 ± 0.98 3.01 ± 0.84
Age
20–30 2.47 ± 0.50 0.45 2.77 ± 0.92 0.19
31–40 2.89 ± 0.62 2.88 ± 0.82
41–50 2.73 ± 0.87 2.78 ± 0.75
More than 51 2.83 ± 1.08 3.15 ± 0.82
Duration of treatment
Less than a month 2.59 ± 0.70 0.04 2.76 ± 0.87 0.39
One to 3 months 2.68 ± 0.80 3.00 ± 0.68
More than 3 months 3.05 ± 0.98 2.99 ± 0.95
Total 2.78 ± 0.86 2.94 ± 0.82
Table3 Correlation between patients’ anxiety and depression
Anxiety/depression Pearson correlation Sig
0.683 0.00
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The study also shows that the least educated patients are
more susceptible to get depressed, which could pertain to lim-
ited or lack of knowledge about cancer and possible health
effects after receiving radiation therapy sessions. Additionally,
results show that patients who have many children are more
depressed and anxious due to their possible fear and continuous
thinking about their children’s future.
Moreover, older cancer patients are more depressed, which
can be explained by their worry of not being able to reach the
radiation treatment facility and the need to have a companion
every time they go for treatment. The elderly also fears of
death from cancer, since many people connect them together.
Also, it was shown that cancer patients are more anxious and
depressed during the first treatment period, since patients are
new to radiation therapy and fear of being irradiated and ther-
apy consequences. These findings agree with a study which
described the effect of age on depression and anxiety [15],
which suggests that, at the start of adjuvant radiotherapy, emo-
tional distress is characterized by anxiety rather than depres-
sion especially for women in their fifties. A Norwegian study
identified higher anxiety levels among mid-age cancer pa-
tients and lower levels of anxiety in patients under 30 and over
70 years old [16]. Patient age at the time of treatment had a
significant influence on psychological distress for cancer pa-
tients undergoing radiotherapy as demonstrated as in similar
studies [17–20].
There was a significant difference in the level of anxiety
with the duration of treatment, especially for treatments over
3 months as reported in a similar study [21], which showed a
higher level of anxiety compared with depression for older
patients receiving radiotherapy for longer periods.
Conclusions
Palestinian cancer patients undergoing radiotherapy demon-
strated substantial levels of emotional depression and anxiety.
Even though the sample size in the current study is small, the
initial results indicate the presence of psychological distress
among cancer patients undergoing radiotherapy in Palestine.
Therefore, addressing these issues improves the quality of life
and gives better adherence to cancer treatment. Results show
that the highest percentage of breast cancer patients treated
with radiation therapy are those having more than 3 children.
Also, the highest anxiety mean was found for those highly
educated (more than BA), whereas the highest depression
mean was found for those who received less than secondary
education. The study also revealed that the lowest anxiety
mean was for those having two children, while the lowest
depression mean was for those having only one child. In order
to help mitigate psychosocial issues, routine screening and
psychosocial support services should be provided for breast
cancer patients. A further step for the current research is to
carry out an investigation regarding the efficacy of available
psychosocial support services on patients’ quality of life and
to improve methods used in reducing psychological distress
for breast cancer patients undergoing radiotherapy.
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